MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from exercises
of warrants, net of...
$14,081K
Proceeds from exercises
of stock options
$2,487K
Proceeds from issuance of
common stock under...
$586K
Net cash provided by
financing activities
$17,154K
Net (decrease)
increase in cash and cash...
-$37,303K
Canceled cashflow
$17,154K
Stock-based compensation
$21,457K
Non-cash lease expense
$1,153K
Accounts payable
$1,132K
Amortization of intangible
assets
$665K
Depreciation
$406K
Net cash used in
operating activities
-$54,122K
Canceled cashflow
$24,813K
Net cash used in
investing activities
-$335K
Net loss
-$72,781K
Accrued liabilities
-$3,450K
Lease liabilities,
net
-$1,368K
Prepaid expenses and
other current assets
$912K
Accounts receivable
$274K
Inventory
$136K
Other non-current
assets
$14K
Purchases of property and
equipment
$315K
Purchases of intangible
assets
$20K
Back
Back
Cash Flow
source: myfinsight.com
PULSE BIOSCIENCES, INC. (PLSE)
PULSE BIOSCIENCES, INC. (PLSE)